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Transdermal drug delivery system (TDDS) may offer an attractive alternative for
the delivery of drugs because it avoids the problems of gastrointestinal intolerance, re-
duces the first-pass liver metabolism and eliminates the need for intravenous access (1).
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Drug-in-adhesive patches (DIAPs) of fentanyl were for-
mulated using various pressure sensitive adhesives (PSAs)
and various chemical permeation enhancers (CPEs). The
effects of PSAs and CPEs on skin permeation of fentanyl
from DIAPs were evaluated using modified jacketed Franz
diffusion cells fitted with excised rat abdominal skin. It
was demonstrated that the permeation rate or steady state
flux (Jss) of the drug through the excised rat skin was de-
pendent on the viscosity and type of acrylic PSA as well
as the type of CPE. Among different acrylic PSAs, Duro-
-Tak® 2054 and Duro-Tak® 2516 showed the highest Jss of
1.95 g cm–2 h–1 and the lowest Jss of 1.43 g cm–2 h–1, re-
spectively. Among the various CPEs used, propylene gly-
col and polyethylene glycol 400 showed 1.61 and 1.18,
the highest and the lowest enhancement ratios (ER) of
the skin permeation of fentanyl, respectively. Oleic acid
and cetyl alcohol moderately increased the skin perme-
ation of fentanyl. It was also shown that increasing the
concentration of CPE led to reduction in the adhesion
property of PSA as measured by the 180° peeling strength
test. Moreover, it was found that the permeation rate in-
creased as the fentanyl loading increased from 1 to 3%.
The skin permeation rate of fentanyl did not increase sig-
nificantly beyond 3% drug loading. It was concluded that
propylene glycol as a CPE and cosolvent in 10% (m/m)
with 3% fentanyl loading in Duro-Tak 2054 showed an
effective monolithic DIAP for the development of a trans-
dermal therapeutic system for fentanyl.
Keywords: fentanyl, permeation enhancer, transdermal
patches, pressure sensitive adhesive, rat skin
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Transdermal delivery of fentanyl provides the ease of application for patients suffering
chronic and post-operative pains. Fentanyl is a narcotic analgesic that predominately in-
teracts with the opioid µ-receptor (2).
The transdermal delivery of drugs depends on their permeability through stratum
corneum (3). There are four strengths of fentanyl transdermal patches on the market
(Duragesic®). Their average flux is 2.5 µg cm–2 h–1. Therefore, this minimum flux should
be obtained during the development of fentanyl TDDS. Many approaches have been
proposed to overcome the low permeability of drugs through the skin. Chemical perme-
ation enhancers (CPEs) are used to promote transdermal delivery of drugs that are in-
sufficiently permeable via skin. Typical CPEs include high-boiling alcohols, diols, fatty
acid esters, oleic acid, sulphoxides, terpenes, surfactants, cyclodextrine and water (4, 5).
They can modify the skin structure and/or make channels in the skin barrier to facilitate
drug transport via skin (6, 7). The CPE type has a significant influence on the develop-
ment of TDDS. Appropriate type and the proper amount of a CPE for a TDDS contain-
ing a specific drug can only be selected by trial and error (8).
All TDDS include a pressure sensitive adhesive (PSA) layer to hold the patch on the
skin. PSAs are materials that adhere to a substrate by application of light force and leave
no residue when removed. Choosing a suitable PSA for a TDDS is not simple because
several requirements should be met. These requirements include no skin irritation or
sensitization, no residue when peeled off from skin and easy removal from skin without
causing pain. Among the three types of PSAs (polyisobutylenes, silicones and acrylic co-
polymers) acrylic PSAs have several desirable features, such as resistance to oxidation
and thermal degradation, permeability for water vapor and oxygen, good tack behavior
and moderate cost (9–11). The PSA adhesive properties in a TDDS depend on the CPE
type and concentration. Several physical tests measure the adhesive properties of TDDS,
e.g., 180° peel strength (12–14).
The present investigation was carried out to study the effects of various acrylic PSAs
and CPEs on in vitro permeability of fentanyl across excised rat abdominal skin in order
to select suitable drug-in-adhesive patches (DIAP) for use in the development of fen-
tanyl TDDS. Different permeation parameters such as lag time (TL), steady state flux (Jss)
and enhancement ratio (ER) were calculated to find the highest permeation rate and the
lowest lag time of fentanyl penetration through stratum corneum.
EXPERIMENTAL
Materials and methods
Micronized fentanyl base was purchased from Diosynth (The Netherlands). Oleic
acid (OA), cetyl alcohol (CA), propylene glycol (PG), polyethylene glycol 400 (PEG 400)
and HPLC grade methanol and acetonitrile were obtained from Merck (Germany). Duro-
-Tak® (2054, 2051 and 2516) and Acronal® acrylic copolymers were gifts from the Na-
tional Starch and Chemical (USA) and BASF (Germany), respectively. These PSAs are
acrylate-vinylacetate copolymers and non-curing pressure sensitive adhesives supplied
in an organic solvent solution. All other chemicals and solvents used in this study were
of analytical grade. CotranTM 9720 (75 µm, polyethylene) backing layer and ScotchpakTM
1022 release liner (also known as peeling or protective liner) were donated by 3M (USA).
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Preparation of DIAPs
DIAPs were prepared by using a quadruple laboratory film applicator with a lateral
guide plate and four thickness choices, 90, 170, 250 and 500 m with 90 mm gap width
(Sandberg & Schneidewind, Germany). The PSAs and CPEs used in the preparation of
fentanyl DIAPs are listed in Tables I and II, respectively. The DIAPs were made of a flex-
ible backing, a PSA containing fentanyl and a release liner. The accurate amount of drug
was weighed and dissolved in acetone; CPE and PSA solution were added to the fen-
tanyl solution and mixed with a magnetic stirrer (IKA, Germany) for 20 min. The con-
centration of each CPE was initially set at 5% of the total mass of the patch. The mixture
was then poured into the trough of the film applicator and spread on the ScotchpakTM
1022 release liner at a constant rate of about 1 m min–1 at a constant wet thickness of 500
m. The films were dried in an oven at 60 °C for 15 min and then cut into predetermined
sizes. The dried film with a thickness of about 150 µm was laminated with CotranTM
9720 backing. Prepared DIAPs were packed in opaque, white heat-sealed pouches (15).
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Table I. Permeation parameters of fentanyl through excised rat skin from drug-in-adhesive patches
prepared using various acrylic pressure sensitive adhesives
DIAP
Permeation parametera
Jss (µg cm–2 h–1) TL (h)
Duro-Tak® 2054 1.95 ± 0.10 6.7 ± 0.4
Acronal® V210 1.71 ± 0.11 8.5 ± 0.6
Duro-Tak® 2051 1.60 ± 0.09 7.0 ± 0.4
Duro-Tak® 2516 1.43 ± 0.06 10.2 ± 0.5
a Mean ± SD, n = 3.
Jss – steady state flux, TL– lag time, DIAP – drug-in-adhesive patch, PSA – pressure sensitive adhesive
Table II. Enhancement ratio values and permeation parameters for four different chemical permeation




Jss (µg cm–2 h–1)a TL (h)a Kp (cm h–1)a ERa
PG 2.86 ± 0.15 3.32 ± 0.20 6.35 × 10–3 1.46 0.49
OA 2.44 ± 0.19 2.36 ± 0.19 5.42 × 10–3 1.25 0.35
CA 2.24 ± 0.12 2.25 ± 0.16 4.97 × 10–3 1.14 0.33
PEG 2.32 ± 0.14 3.66 ± 0.28 5.15 × 10–3 1.18 0.54
a Mean ± SD, n = 3.
CPE – chemical permeaction enhancer, ER – enhancement ratio, Jss, TL Kp and ER denote the steady state flux,
lag time, permeation coefficient and enhancement ratio, respectively. TL ratio is the quotient of lag time of
transdermal patch with CPE to the lag time of the formulation without CPE.
PG, OA, CA and PEG denote propylene glycol, oleic acid, cetyl alcohol and polyethylene glycol, respectively.
Measurement of fentanyl skin permeation
Preparation of rat abdominal skin. – Male Sprague-Dawley rats (150–200 g) obtained
from the animal house of the Faculty of Pharmacy (Tehran, Iran) were sacrificed using
diethyl ether asphyxiation. Hair of the abdominal region was carefully removed and a 5
cm × 6 cm full-thickness skin was excised from this region from each sacrificed rat. Sub-
cutaneous fat was carefully removed with a scalpel. Excised rat skins were dipped and
soaked in a saline normal solution at ambient temperature and transferred for the in vi-
tro skin permeation study within 3–4 hours.
Permission for the experiment was given by the Ethics Committee of the Tehran
University of Medical Sciences.
In vitro permeation studies. – Permeation investigation was carried out using excised
rat abdominal skin in a modified jacketed Franz diffusion cell with a 1.2 cm2 effective
diffusion area. Receptor compartment of the diffusion cell was completely filled with 5.6
mL of filtered and degassed phosphate buffer solution (PBS), pH 7.2, as receiver me-
dium. Excess water was removed from the surface of the skin by gentle rubbing with
lint-free tissue paper. The DIAP was applied to the epidermal side of the rat skin with
slight pressure and then mounted over the receptor compartment. The O-ring and donor
chamber with a pre-greased flange were placed over the DIAP. Any air bubbles that re-
mained in the receptor compartment and below the skin were carefully removed by gen-
tle tilting of the diffusion cell. The receptor medium was stirred by a magnetic stirrer
(IKA, Germany) and the temperature was maintained at 32 ± 0.5 °C using a thermostatic
water pump bath (Brookfield, TC-101, USA). To maintain the sink condition throughout
the experiments, at predetermined time intervals (2, 4, 8, 12, 24, 32, 48 and 72 h) the re-
ceptor medium was completely withdrawn from the receptor compartment and replac-
ed with fresh PBS.
The concentration of fentanyl was determined at each sampling by a fully-validated
HPLC method (16) and the cumulative amount of fentanyl was calculated.
HPLC analysis of fentanyl. – Quantitative determination of fentanyl was performed
by High Performance Liquid Chromatograph (Waters 486, USA). Chromatographic se-
paration was performed on a C18, 250 × 4.6 mm, 5 m, column (Capital, UK). A similar
guard column was used to prevent obstruction by minute particles. The mobile phase
consisted of 40 volumes of ammonium acetate solution (1%) and 60 volumes of a mix-
ture of methanol, acetonitril, and glacial acetic acid (400:600:0.6). The mobile phase pH
was adjusted to 6.6 ± 0.1 by drop-wise addition of glacial acetic acid. The elute was mo-
nitored at 230 nm and the retention time of fentanyl and the mobile phase flow rate were
4.2 minutes and 2 mL min–1, respectively (16).
Evaluation of adhesive properties. – The adhesive strength of the DIAPs was determi-
ned using an adhesion/release apparatus (Cheminstruments, AR 1000, USA) and by ap-
plying the 180° peel test according to the American Standard Test Methods (ASTM). The
objective of the 180° peel test is to determine the peel force, in cN per cm, needed to re-
move the TDDS from the release liner using a 180° peel angle at a constant peel rate of
15.2 cm min–1. DIAP samples were prepared as ribbons of 25 mm width and 305 mm
length (12, 14, 17).
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Data analysis
Cumulative amounts of fentanyl that permeated through excised rat skin were plot-
ted as a function of time. Steady state flux was expressed as the slope of the linear por-
tion of the resulting permeation profile (Jss, µg cm–2 h–1) by regression analysis. Lag time
(TL, h) was determined by extrapolating the linear portion of the permeation profile to
the x-axis (18, 19).






where Jss is the steady state flux and cv is the initial concentration of fentanyl in the do-
nor compartment. The penetration enhancing effect of the CPE was calculated in terms







All skin permeation experiments were repeated three times, and their mean values
are presented with the corresponding standard deviations. Student’s t-test was performed
to find the significant difference, if any, in the permeation rate between the DIAP con-
taining CPE and enhancer-free formulations (control).
RESULTS AND DISCUSSION
Selection of receptor medium
According to our results, the solubility of fentanyl at 32 °C in water and PBS, pH
7.2, was 95 and 731 µg mL–1, respectively. Thus, PBS can be a suitable receptor medium,
because the loading of fentanyl in DIAP is 4.5 mg per 10 cm2, so the amount of fentanyl
in the effective area of the diffusion cell (1.2 cm2) is less than the amount required to ex-
ceed the sink condition. On the other hand, it was found that the solubility of fentanyl in
water containing 5% methanol and sodium lauryl sulfate 1% solution in water is much
more than the sink condition. It may lead to loss of the discriminative property of disso-
lution medium (15).
Rat skin permeation parameters
Influence of various PSAs on skin permeation. – The skin permeation rate of fentanyl
through excised rat abdominal skin from different DIAPs prepared with various acrylic
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PSAs was determined. The permeation profiles of fentanyl are shown in Fig. 1a. Perme-
ation parameters, including the permeation rate or steady state flux (Jss) and lag time
(TL), were calculated from the profiles and are presented in Table I. The permeation rates
of fentanyl from DIAPs through rat skin were in the range 1.43–1.95 µg cm–2 h–1. Among
four different PSAs used in this study, Duro-Tak® 2054 resulted in the highest skin per-
meation rate of fentanyl (1.95 µg cm–2 h–1), while Duro-Tak® 2516 showed the lowest
permeation rate (1.43 µg cm–2 h–1). These results may be explained by the viscosity and
the amount of solid content. According to the manufacturer’s leaflet, the viscosities of
Duro-Tak® 2054 and Duro-Tak® 2516 are 2275 and 4350 mPa s, respectively. Also, there
were significant differences in the lag time between the PSAs, ranging from 6.7 to 10.2 h
(p < 0.05). Subsequently, Duro-Tak® 2054 was used in further development of the fenta-
nyl DIAP, because it revealed the highest steady state flux and the shortest lag time,
which are essential for getting an appropriate therapeutical effect of fentanyl.
Influence of fentanyl loading in the acrylic PSA on skin permeation. – The permeation
rate increased as the drug loading increased from 1 to 3%. From Fig. 2 it is clear that the
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Fig. 1. Permeation profiles of fentanyl
through excised rat abdominal skin from
different drug-in-adhesive patches pre-
pared using: a) various pressure sensi-
tive adhesives:  – Duro-Tak® 2054, 
– Duro-Tak® 2051,  – Acronal®, and
 – Duro-Tak® 2516; b) Duro-Tak 2054
and various chemical permeation:  –
propylene glycol (5%),  – oleic acid
(5%),  – cetyl alcohol (5%),  – poly-
ethylene glycol 400 (5%) and  – en-
hancer-free drug-in-adhesive patch (con-
trol). Each value is a mean of three tests
with the corresponding SD bar.
a)
b)
skin permeation rate of fentanyl did not increase significantly beyond 3% drug loading.
The results suggested that drug loading in the acrylic PSA had reached maximum diffu-
sion of molecules through their matrix and transport of fentanyl through rat skin be-
yond 3% and it was limited by dissolution of an excess of dispersed drug crystals in the
acrylic PSA.
Influence of CPEs on skin permeation. – Incorporation of CPEs in the DIAP was essen-
tial for increasing the permeation rate of fentanyl from the patches. In this study, two
lipophilic and two hydrophilic CPEs were selected and their effects on the permeation of
fentanyl from DIAPs prepared with Duro-Tak 2054 (which in our previous study show-
ed the highest permeation rate, data not shown) through excised rat skin were investi-
gated at a preliminary concentration of 5%. The skin permeation profiles of the drug
from the DIAPs are shown in Fig. 1b. The permeation parameters calculated from the
obtained profiles are presented in Table II.
Among the various CPEs used, PG showed the highest enhancing effect for fentan-
yl. The mechanism of action of various CPEs may be attributed to their activity on lipo-
philic matrix and/or hydrophilic protein gel in stratum corneum (18). CPEs act through
interaction with intercellular lipids, leading to disruption of their organization and in-
creasing their fluidity. Some of them also interact with intercellular protein, keratin de-
naturation (e.g., oleic acid), while PG acts by both mechanisms (5). These last enhance-
ment mechanisms are consistent with the findings obtained in our experiments. On the
other hand, OA, CA and PEG 400 moderately increased the skin permeation of fentanyl.
There are no significant differences between their Jsss, but their differences are significant
compared to PG.
Incorporation of PG into the acrylic PSA matrix significantly enhanced the perme-
ation rate and shortened the TL of fentanyl. In conclusion, the maximum Jss obtained
from DIAP prepared with Duro-Tak 2054 and 5% PG was 2.86 µg cm–2 h–1. Among these
CPEs, the lag time was predominately reduced by two lipophilic enhancers, OA and CA.
This phenomenon may be explained by the lipophilic characteristics of both of them.
Thus, they can cause more disruption of the lipid matrix of stratum corneum and faster
penetration of fentanyl through skin.
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Fig. 2. Influence of drug loading
on skin permeation of fentanyl
patches. Each value is a mean of
three tests with the correspond-
ing standard deviation.
The enhancing effects of PG and OA were further evaluated at 10% and 15% con-
centrations in the DIAPs prepared with Duro-Tak 2054 (Table III). The permeation rates
at three concentrations of PG and OA, calculated from the permeation profiles, are shown
in Fig. 3. The permeation rate reached a plateau for OA and PG at the level of 5 and 10%,
respectively. It showed that the aforementioned concentrations of OA and PG are the op-
timal concentrations for enhancing the permeation of fentanyl. The steady state flux (Jss)
obtained from DIAP prepared with Duro-Tak 2054 and 10% PG and 5% OAwere 3.16 and
2.48 µg cm–2 h–1, respectively.
Although the addition of 15% PG or 10% OA did not further increase the Jss of fen-
tanyl, it reduced the lag time. It should be noted that the excessive or inappropriate us-
age of CPEs may lead to loss of the PSA’s mechanical properties (10). In Table III, it is
shown that the adhesive property as measured by the 180° peeling test was reduced by
increasing the CPE concentration. As mentioned, OA significantly decreased the lag time
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Jss (g cm–2 h–1)a Peeling strength (cN cm
–1)a TL (h)a
PG OA PG OA PG OA
0 1.95 ± 0.10 425 ± 27 6.7 ± 0.4
5 2.86 ± 0.15 2.44 ± 0.19 365 ± 22 285 ± 25 3.32 ± 0.2 2.36 ± 0.19
10 3.16 ± 0.28 2.48 ± 0.17 307 ± 31 245 ± 18 2.95 ± 0.23 2.20 ± 0.20
15 3.05 ± 0.24 2.39 ± 0.21 253 ± 12 181 ± 23 2.75 ± 0.16 2.05 ± 0.14
a Mean ± SD, n = 3.
Jss – steady state flux, TL – lag time, PG – polyethyleneglycol, OA – oleic acid, CPE – chemical permeation
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Fig. 3. Effects of the concentration of
propylene glycol and oleic acid on the
permeation rate of fentanyl through ex-
cised rat skin:  – propylene glycol, 
– oleic acid. Each value is a mean of
three tests with the corresponding SD.
(Table III); another reason for this observation is further loss the adhesion property of
PSA by OA. It is noticeable that the peeling strength less than 300 cN cm–1 may lead to
poor adhesion (21).
CONCLUSIONS
The permeation rate of fentanyl in Duro-Tak® 2054 was the highest among the four
PSAs examined. It was clearly demonstrated that PG showed the highest steady state
flux among four the chemical permeation enhancers tested. On the other hand, it was
found that the skin flux of fentanyl increased as the drug loading in the acrylic PSA in-
creased from 1 to 3%, and reached a plateau beyond 3% drug loading.
In summary, the results indicate that the use of PG as CPE and cosolvent (10%, m/m)
with 3% fentanyl loading in Duro-Tak 2054 is an effective monolithic DIAP for the devel-
opment of a transdermal therapeutic system for fentanyl. As mentioned, increasing the
concentration of PG as CPE led to improvement of Jss but decreased the adhesion strength.
This defect may be explained by excessive plasticizing of PSA resulting in poor adhesion
(22). This research work showed that the PSAs that are commonly used in TDDS are not
tolerant to enhancers.
The maximum Jss (3.16 g cm–2 h–1) obtained from DIAP prepared with acrylic PSA
seemed to be high enough to achieve therapeutic effects. Lag time was decreased to around
3 h by selecting the 10% PG as CPE and Duro-Tak 2054 as PSA.
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S A @ E T A K
U~inci adheziva osjetljivih na tlak i kemijskih promotora na
permeaciju fentanila kroz ko`u {takora
AMIR MEHDIZADEH, MOHAMMAD HOSSAIN GHAHREMANI, MOHAMMAD REZA ROUINI i TAYEBEH TOLIYAT
Pripravljeni su transdermalni adhezivni flasteri fentanila (DIAPs) koriste}i razli~ite
adhezive osjetljivih na tlak (PSAs) i kemijske promotore permeabilnosti (CPEs). Njihovi
u~inci na permeabilnost fentanila evaluirani su pomo}u modificirane Franzove difuzij-
ske }elije s membranom od ko`e s abdomena {takora. Brzina permeacije (Jss) ovisi o vis-
koznosti i vrsti akrilnih adheziva i o vrsti promotora. Najve}a vrijednost Jss = 1,95 g
cm–2 h–1 postignuta je s Duro-Tak® 2054, a najmanja (Jss = 1,43 g cm–2 h–1) s Duro-Tak®
2516. Me|u razli~itim promotorima propilen glikol i polietilen glikol 400 pokazali su
najve}i (1,61) i najmanji (1,18) omjer pobolj{anja (ER) permeabilnosti. Oleinska kiselina i
cetil alkohol umjereno su pove}ali permeabilnost fentanila. Za mjerenje adhezivnih svoj-
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stava upotrebljena je »metoda lju{tenja«. Pove}anje koncentracije CPE smanjilo je adhe-
zivna svojstva PSA. Kada je udio fentanila u flasteru povi{en s 1 na 3%, brzina permea-
cije se pove}ala, dok daljnje pove}anje udjela fentanila nije zna~ajno utjecalo na brzi- nu.
Pripravak s 10% propilen glikola i 3% fentanila u Duro-Tak 2054 pokazao se kao u~in-
koviti transdermalni terapijski sustav za fentanil.
Klju~ne rije~i: fentanil, promotor permeabilnosti, transdermalni flasteri, adhezivi osjetljivi na tlak,
ko`a {takora
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